Global Tumor Necrosis Factor Inhibitor Drug Market Insights, Trends and Growth Outlook 2021 - 2028
1 Study Coverage
1.1 Tumor Necrosis Factor Inhibitor Drug Product Introduction
1.2 Market by Type
1.2.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size Growth Rate by Type
1.2.2 Humira
1.2.3 Enbrel
1.2.4 Remicade
1.2.5 Simponi
1.2.6 Cimzia
1.2.7 Biosimilars
1.3 Market by Application
1.3.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size Growth Rate by Application
1.3.2 Rheumatoid Arthritis
1.3.3 Psoriatic Arthritis
1.3.4 Juvenile Idiopathic Arthritis
1.3.5 Crohn’s Disease
1.3.6 Ulcerative Colitis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size, Estimates and Forecasts
2.1.1 Global Tumor Necrosis Factor Inhibitor Drug Revenue 2016-2027
2.1.2 Global Tumor Necrosis Factor Inhibitor Drug Sales 2016-2027
2.2 Global Tumor Necrosis Factor Inhibitor Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Tumor Necrosis Factor Inhibitor Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Tumor Necrosis Factor Inhibitor Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Tumor Necrosis Factor Inhibitor Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Tumor Necrosis Factor Inhibitor Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Region (2022-2027)
3 Global Tumor Necrosis Factor Inhibitor Drug Competitor Landscape by Players
3.1 Global Top Tumor Necrosis Factor Inhibitor Drug Manufacturers by Sales
3.1.1 Global Tumor Necrosis Factor Inhibitor Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Tumor Necrosis Factor Inhibitor Drug Manufacturers by Revenue
3.2.1 Key Tumor Necrosis Factor Inhibitor Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Tumor Necrosis Factor Inhibitor Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Tumor Necrosis Factor Inhibitor Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Tumor Necrosis Factor Inhibitor Drug Revenue in 2020
3.2.6 Global Tumor Necrosis Factor Inhibitor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tumor Necrosis Factor Inhibitor Drug Price by Manufacturers
3.4 Global Tumor Necrosis Factor Inhibitor Drug Manufacturing Base Distribution, Product Types
3.4.1 Tumor Necrosis Factor Inhibitor Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tumor Necrosis Factor Inhibitor Drug Product Type
3.4.3 Date of International Manufacturers Enter into Tumor Necrosis Factor Inhibitor Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size by Type (2016-2021)
4.1.1 Global Tumor Necrosis Factor Inhibitor Drug Sales by Type (2016-2021)
4.1.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue by Type (2016-2021)
4.1.3 Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Tumor Necrosis Factor Inhibitor Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Type (2022-2027)
4.2.3 Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size by Application (2016-2021)
5.1.1 Global Tumor Necrosis Factor Inhibitor Drug Sales by Application (2016-2021)
5.1.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue by Application (2016-2021)
5.1.3 Tumor Necrosis Factor Inhibitor Drug Price by Application (2016-2021)
5.2 Tumor Necrosis Factor Inhibitor Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Tumor Necrosis Factor Inhibitor Drug Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
6.1.1 United States Tumor Necrosis Factor Inhibitor Drug Sales YoY Growth 2016-2027
6.1.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue YoY Growth 2016-2027
6.1.3 United States Tumor Necrosis Factor Inhibitor Drug Market Share in Global Market 2016-2027
6.2 United States Tumor Necrosis Factor Inhibitor Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Tumor Necrosis Factor Inhibitor Drug Players by Sales (2016-2021)
6.2.2 United States Top Tumor Necrosis Factor Inhibitor Drug Players by Revenue (2016-2021)
6.3 United States Tumor Necrosis Factor Inhibitor Drug Historic Market Review by Type (2016-2021)
6.3.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Type (2016-2021)
6.3.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Type (2016-2021)
6.3.3 United States Tumor Necrosis Factor Inhibitor Drug Price by Type (2016-2021)
6.4 United States Tumor Necrosis Factor Inhibitor Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Type (2022-2027)
6.4.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Type (2022-2027)
6.4.3 United States Tumor Necrosis Factor Inhibitor Drug Price Forecast by Type (2022-2027)
6.5 United States Tumor Necrosis Factor Inhibitor Drug Historic Market Review by Application (2016-2021)
6.5.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Application (2016-2021)
6.5.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Application (2016-2021)
6.5.3 United States Tumor Necrosis Factor Inhibitor Drug Price by Application (2016-2021)
6.6 United States Tumor Necrosis Factor Inhibitor Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Application (2022-2027)
6.6.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Application (2022-2027)
6.6.3 United States Tumor Necrosis Factor Inhibitor Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
7.2 North America Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
7.2.1 North America Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
7.2.2 North America Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
9.2 Europe Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
9.2.1 Europe Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
9.2.2 Europe Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
10.2 Latin America Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
10.2.1 Latin America Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
10.2.2 Latin America Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AbbVie Inc.
12.1.1 AbbVie Inc. Corporation Information
12.1.2 AbbVie Inc. Description and Business Overview
12.1.3 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
12.1.5 AbbVie Inc. Recent Development
12.2 Amgen Inc.
12.2.1 Amgen Inc. Corporation Information
12.2.2 Amgen Inc. Description and Business Overview
12.2.3 Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
12.2.5 Amgen Inc. Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 UCB
12.4.1 UCB Corporation Information
12.4.2 UCB Description and Business Overview
12.4.3 UCB Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 UCB Tumor Necrosis Factor Inhibitor Drug Products Offered
12.4.5 UCB Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Corporation Information
12.5.2 Novartis AG Description and Business Overview
12.5.3 Novartis AG Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novartis AG Tumor Necrosis Factor Inhibitor Drug Products Offered
12.5.5 Novartis AG Recent Development
12.6 Pfizer, Inc.
12.6.1 Pfizer, Inc. Corporation Information
12.6.2 Pfizer, Inc. Description and Business Overview
12.6.3 Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
12.6.5 Pfizer, Inc. Recent Development
12.7 Merck & Co., Inc.
12.7.1 Merck & Co., Inc. Corporation Information
12.7.2 Merck & Co., Inc. Description and Business Overview
12.7.3 Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
12.7.5 Merck & Co., Inc. Recent Development
12.8 CASI Pharmaceuticals
12.8.1 CASI Pharmaceuticals Corporation Information
12.8.2 CASI Pharmaceuticals Description and Business Overview
12.8.3 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Products Offered
12.8.5 CASI Pharmaceuticals Recent Development
12.9 EPIRUS Biopharmaceuticals
12.9.1 EPIRUS Biopharmaceuticals Corporation Information
12.9.2 EPIRUS Biopharmaceuticals Description and Business Overview
12.9.3 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Products Offered
12.9.5 EPIRUS Biopharmaceuticals Recent Development
12.10 LEO Pharma
12.10.1 LEO Pharma Corporation Information
12.10.2 LEO Pharma Description and Business Overview
12.10.3 LEO Pharma Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 LEO Pharma Tumor Necrosis Factor Inhibitor Drug Products Offered
12.10.5 LEO Pharma Recent Development
12.11 AbbVie Inc.
12.11.1 AbbVie Inc. Corporation Information
12.11.2 AbbVie Inc. Description and Business Overview
12.11.3 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
12.11.5 AbbVie Inc. Recent Development
12.12 Shanghai Pharmaceuticals Holding Co., Ltd.
12.12.1 Shanghai Pharmaceuticals Holding Co., Ltd. Corporation Information
12.12.2 Shanghai Pharmaceuticals Holding Co., Ltd. Description and Business Overview
12.12.3 Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shanghai Pharmaceuticals Holding Co., Ltd. Products Offered
12.12.5 Shanghai Pharmaceuticals Holding Co., Ltd. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Tumor Necrosis Factor Inhibitor Drug Industry Trends
13.2 Tumor Necrosis Factor Inhibitor Drug Market Drivers
13.3 Tumor Necrosis Factor Inhibitor Drug Market Challenges
13.4 Tumor Necrosis Factor Inhibitor Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tumor Necrosis Factor Inhibitor Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details